European Journal of Cancer
Volume 41, Issue 14 , Pages 2079-2085, September 2005

Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution

  • Gaetano Bacci

      Affiliations

    • Chemotherapy, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 051 6366 829; fax: +39 051 6366 277.
    • ,
  • Mario Mercuri

      Affiliations

    • Orthopaedic Surgery, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • ,
  • Alessandra Longhi

      Affiliations

    • Chemotherapy, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • ,
  • Stefano Ferrari

      Affiliations

    • Chemotherapy, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • ,
  • Franco Bertoni

      Affiliations

    • Pathology, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • ,
  • Michela Versari

      Affiliations

    • Chemotherapy, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • ,
  • Piero Picci

      Affiliations

    • Oncologic Research, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy

Received 17 December 2004; received in revised form 31 March 2005; accepted 31 March 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(05)00558-7

doi:10.1016/j.ejca.2005.03.036

European Journal of Cancer
Volume 41, Issue 14 , Pages 2079-2085, September 2005

Article Tools